Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2019

Lee JY, Schizas M, Geyer FC, Selenica P, Piscuoglio S, Sakr RA, et al. Lobular Carcinomas Display Intralesion Genetic Heterogeneity and Clonal Evolution in the Progression to Invasive Lobular Carcinoma. Clin Cancer Res. 2019;25(2):674-686.

Irey EA, Lassiter CM, Brady NJ, Chuntova P, Wang Y, Knutson TP, et al. JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors. Proc Natl Acad Sci U S A. 2019;116(25):12442-12451.

Baum J, Magpayo J, Hoda S. Getting on the Nerves: A Case of Perineural Invasion by Mammary Ductal Carcinoma In Situ. Int J Surg Pathol. 2019;27(6):647-648.

Goren L, Zhang G, Kaushik S, Breslin PA, Du Y-, Foster DA. (-)-Oleocanthal and (-)-oleocanthal-rich olive oils induce lysosomal membrane permeabilization in cancer cells. PLoS One. 2019;14(8):e0216024.

Magro CM, Momtahen S, Coleman M, Grossman ME. Epidermotropic CXCR3 positive marginal zone lymphoma: a distinctive clinical histopathological entity potentially originating in the skin; it does not always indicate splenic marginal zone lymphoma. Dermatol Online J. 2019;25(7).

Goel R, Vasovic LV, Westblade LF, Harris R, D'Ambrosio D, Emmons F, et al. The power of a trained eye: fatal transfusion-transmitted anaplasmosis and a case study in investigative work. Transfusion. 2019;59(2):444-445.

Wang Y, Lu S, Xiong J, Singh K, Hui Y, Zhao C, et al. ColXα1 is a stromal component that colocalizes with elastin in the breast tumor extracellular matrix. J Pathol Clin Res. 2019;5(1):40-52.

Roe CJ, Siddiqui MT, Lawson D, Cohen C. RNA In Situ Hybridization for Epstein-Barr Virus and Cytomegalovirus: Comparison With In Situ Hybridization and Immunohistochemistry. Appl Immunohistochem Mol Morphol. 2019;27(2):155-159.

Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, et al. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res. 2019;25(4):1280-1290.

Zadra G, Loda M. When fat goes down, prostate cancer is on the ropes. Mol Cell Oncol. 2019;6(3):1595308.